142 related articles for article (PubMed ID: 18194414)
21. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
Tullett J; Murray E; Nichols L; Holder R; Lester W; Rose P; Hobbs FD; Fitzmaurice D
BMC Cardiovasc Disord; 2013 Mar; 13():16. PubMed ID: 23497371
[TBL] [Abstract][Full Text] [Related]
22. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
Vene N; Mavri A; Kosmelj K; Stegnar M
Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
[TBL] [Abstract][Full Text] [Related]
23. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
[TBL] [Abstract][Full Text] [Related]
24. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
[TBL] [Abstract][Full Text] [Related]
25. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
[TBL] [Abstract][Full Text] [Related]
26. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
[TBL] [Abstract][Full Text] [Related]
27. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.
Samama MM; Horellou MH; Elalamy I; Mathieux V; Ombandza-Moussa E; Conard J
Semin Vasc Med; 2005 Nov; 5(4):371-4. PubMed ID: 16302158
[TBL] [Abstract][Full Text] [Related]
28. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
Jafri SM; Mammen EF; Masura J; Goldstein S
Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
[TBL] [Abstract][Full Text] [Related]
29. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
[TBL] [Abstract][Full Text] [Related]
30. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409
[TBL] [Abstract][Full Text] [Related]
31. Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis.
Bruinstroop E; Klok FA; Van De Ree MA; Oosterwijk FL; Huisman MV
J Thromb Haemost; 2009 Apr; 7(4):611-8. PubMed ID: 19175498
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Marongiu F; Palareti G;
Blood; 2010 Jan; 115(3):481-8. PubMed ID: 19965693
[TBL] [Abstract][Full Text] [Related]
33. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.
Palareti G; Legnani C; Antonucci E; Cosmi B; Poli D; Testa S; Tosetto A; Ageno W; Falanga A; Ferrini PM; Pengo V; Prandoni P;
Intern Emerg Med; 2020 Apr; 15(3):453-462. PubMed ID: 31691119
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
35. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Kearon C; Julian JA; Kovacs MJ; Anderson DR; Wells P; Mackinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M; Ginsberg JS;
Blood; 2008 Dec; 112(12):4432-6. PubMed ID: 18791166
[TBL] [Abstract][Full Text] [Related]
36. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
[TBL] [Abstract][Full Text] [Related]
37. Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism?
Ho WK; Hankey GJ; Eikelboom JW
Med J Aust; 2011 Aug; 195(3):139-42. PubMed ID: 21806532
[TBL] [Abstract][Full Text] [Related]
38. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
[TBL] [Abstract][Full Text] [Related]
39. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
[TBL] [Abstract][Full Text] [Related]
40. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
